Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease

Volume: 2, Issue: 7, Pages: 1148 - 1151
Published: Jul 1, 2021
Abstract

Key Points

This is the first report to describe dose dependency in the effects of tolvaptan treatment for autosomal dominant polycystic kidney disease. The weight-adjusted average daily dose of tolvaptan was found to be a factor that significantly affected the change in eGFR. If a patient shows tolerance, increasing the tolvaptan dose to the maximum should be...
Paper Details
Title
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease
Published Date
Jul 1, 2021
Journal
Volume
2
Issue
7
Pages
1148 - 1151
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.